NYSE · RMD
ResMed Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for RMD has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.67 | $2.71 | $2.63 | 5 |
| Dec 2026 | $3.03 | $3.06 | $3.01 | 5 |
| Mar 2027 | $3.15 | $3.21 | $3.08 | 5 |
| Jun 2027 | $3.26 | $3.29 | $3.23 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · MarketBeat · Fintel- Zacks · Oct 29, 8:45 AM EDTHere's Why ResMed (RMD) is a Strong Growth StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Zacks · Oct 28, 8:15 AM EDTUnlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key MetricsLooking beyond Wall Street's top-and-bottom-line estimate forecasts for ResMed (RMD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
- Zacks · Oct 27, 7:55 AM EDTWhy Investors Need to Take Advantage of These 2 Medical Stocks NowWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks · Oct 23, 11:10 AM EDTWill ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks · Oct 23, 7:55 AM EDTResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?RMD heads into Q1 fiscal 2027 earnings with sleep device demand and new product launches supporting growth, while MatrixCare's divestiture weighs on revenues.
- Zacks · Oct 22, 9:00 AM EDTResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- BNK Invest · Oct 21, 10:56 AM EDTIHI, MDT, RMD, BDX: Large Outflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Medical Devices ETF (Symbol: IHI) where we have detected an approximate $317.5 million dollar outflow — that's a 8.5% decrease week ov
- BNK Invest · Oct 7, 4:15 PM EDTResMed Breaks Above 200-Day Moving Average – Bullish for RMDIn trading on Wednesday, shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $225.46, changing hands as high as $228.75 per share. ResMed Inc. shares are currently trading up about 2.7% on the day. The chart below shows the one year performance of
- MarketBeat · Sep 21, 4:02 PM EDTResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy DemandHCA Healthcare Rallies: Weight-loss drugs really a big threat?ResMed (NYSE:RMD) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing product innovation in
- BNK Invest · Sep 15, 4:20 PM EDTBullish Two Hundred Day Moving Average Cross – RMDIn trading on Tuesday, shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $227.72, changing hands as high as $234.33 per share. ResMed Inc. shares are currently trading up about 3.7% on the day. The chart below shows the one year performance of R
- Fintel · Sep 15, 2:31 PM EDTRBC Capital Upgrades ResMed to Outperform from Sector PerformFintel reports that on September 15, 2026, RBC Capital upgraded their outlook for ResMed (NYSE:RMD) from Sector Perform to Outperform.This upgrade follows a prior action on August 7, 2026, when RBC Capital maintained its Sector Perform rating on the stock. Other analysts have als
- Zacks · Sep 15, 10:10 AM EDTIs This the Right Time to Retain Resmed Stock in Your Portfolio?RMD's software portfolio optimization, mask innovation and solid financial health support growth, though macro pressures and competition pose risks.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for ResMed Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.